Literature DB >> 22383567

Biological insights from clinical trials and networks.

Victor J Thannickal, James S Hagood.   

Abstract

Mesh：

Substances：

Year:  2012        PMID： 22383567      PMCID： PMC3297100          DOI： 10.1164/rccm.201201-0047ED

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN： 1073-449X            Impact factor:   21.405


× No keyword cloud information.
  10 in total

Review 1.  Potential role of statins on wound healing: review of the literature.

Authors:  Shadi Farsaei; Hossein Khalili; Effat Sadat Farboud
Journal:  Int Wound J       Date:  2011-11-04       Impact factor: 3.315

2.  Extracellular ATP is a danger signal activating P2X7 receptor in lung inflammation and fibrosis.

Authors:  Nicolas Riteau; Pamela Gasse; Louis Fauconnier; Aurélie Gombault; Marion Couegnat; Lizette Fick; Jean Kanellopoulos; Valérie F J Quesniaux; Sylvain Marchand-Adam; Bruno Crestani; Bernhard Ryffel; Isabelle Couillin
Journal:  Am J Respir Crit Care Med       Date:  2010-06-03       Impact factor: 21.405

3.  Statins and pulmonary fibrosis: the potential role of NLRP3 inflammasome activation.

Authors:  Jin-Fu Xu; George R Washko; Kiichi Nakahira; Hiroto Hatabu; Avignat S Patel; Isis E Fernandez; Mizuki Nishino; Yuka Okajima; Tsuneo Yamashiro; James C Ross; Raúl San José Estépar; Alejandro A Diaz; Hui-Ping Li; Jie-Ming Qu; Blanca E Himes; Carolyn E Come; Katherine D'Aco; Fernando J Martinez; MeiLan K Han; David A Lynch; James D Crapo; Danielle Morse; Stefan W Ryter; Edwin K Silverman; Ivan O Rosas; Augustine M K Choi; Gary M Hunninghake
Journal:  Am J Respir Crit Care Med       Date:  2012-01-12       Impact factor: 21.405

Review 4.  Pleiotropic effects of statins. - Basic research and clinical perspectives -.

Authors:  Qian Zhou; James K Liao
Journal:  Circ J       Date:  2010-04-15       Impact factor: 2.993

5.  The inflammasome activating caspase 1 mediates fibrosis and myofibroblast differentiation in systemic sclerosis.

Authors:  Carol M Artlett; Sihem Sassi-Gaha; Judy L Rieger; Alina C Boesteanu; Carol A Feghali-Bostwick; Peter D Katsikis
Journal:  Arthritis Rheum       Date:  2011-11

6.  The Nalp3 inflammasome is essential for the development of silicosis.

Authors:  Suzanne L Cassel; Stephanie C Eisenbarth; Shankar S Iyer; Jeffrey J Sadler; Oscar R Colegio; Linda A Tephly; A Brent Carter; Paul B Rothman; Richard A Flavell; Fayyaz S Sutterwala
Journal:  Proc Natl Acad Sci U S A       Date:  2008-06-24       Impact factor: 11.205

7.  Innate immune activation through Nalp3 inflammasome sensing of asbestos and silica.

Authors:  Catherine Dostert; Virginie Pétrilli; Robin Van Bruggen; Chad Steele; Brooke T Mossman; Jürg Tschopp
Journal:  Science       Date:  2008-04-10       Impact factor: 47.728

8.  Lung volumes and emphysema in smokers with interstitial lung abnormalities.

Authors:  George R Washko; Gary M Hunninghake; Isis E Fernandez; Mizuki Nishino; Yuka Okajima; Tsuneo Yamashiro; James C Ross; Raúl San José Estépar; David A Lynch; John M Brehm; Katherine P Andriole; Alejandro A Diaz; Ramin Khorasani; Katherine D'Aco; Frank C Sciurba; Edwin K Silverman; Hiroto Hatabu; Ivan O Rosas
Journal:  N Engl J Med       Date:  2011-03-10       Impact factor: 91.245

9.  Potential role of the inflammasome-derived inflammatory cytokines in pulmonary fibrosis.

Authors:  Rupa Biswas; Melisa Bunderson-Schelvan; Andrij Holian
Journal:  Pulm Med       Date:  2011-06-02

10.  Heightened inflammasome activation is linked to age-related cognitive impairment in Fischer 344 rats.

Authors:  Lana J Mawhinney; Juan Pablo de Rivero Vaccari; Gordon A Dale; Robert W Keane; Helen M Bramlett
Journal:  BMC Neurosci       Date:  2011-12-01       Impact factor: 3.288
  10 in total
  1 in total

Review 1.  Targeting the mevalonate cascade as a new therapeutic approach in heart disease, cancer and pulmonary disease.

Authors:  Behzad Yeganeh; Emilia Wiechec; Sudharsana R Ande; Pawan Sharma; Adel Rezaei Moghadam; Martin Post; Darren H Freed; Mohammad Hashemi; Shahla Shojaei; Amir A Zeki; Saeid Ghavami
Journal:  Pharmacol Ther       Date:  2014-02-26       Impact factor: 12.310
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.